Full Text View
Tabular View
No Study Results Posted
Related Studies
The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS
This study has been completed.
Study NCT00413361   Information provided by Assistance Publique - Hôpitaux de Paris

First Received on December 18, 2006.   Last Updated on January 26, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systemic Lupus Erythematosus
Additional conditions recognized in this trial
Lupus Erythematosus, Systemic
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Interventions listed in this trial
versus hydroxychloroquine
Additional drug interventions recognized in this trial
Hydroxychloroquine
More general drug interventions related to this trial
Anti-Infective Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris
Sanofi-Synthelabo


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services